<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39385302</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Systematic review of case reports on COVID-19 associated myocarditis: a discussion on treatments.</ArticleTitle><Pagination><StartPage>252</StartPage><MedlinePgn>252</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">252</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-024-02499-4</ELocationID><Abstract><AbstractText>Although COVID-19 is a disease consisting of mostly upper and lower respiratory symptoms, a subset of patients develop cardiac sequelae including myocarditis and pericarditis. For these patients, a standardized set of diagnostic imaging techniques and treatments has not been established. While there have been numerous case reports on this topic, there are few reviews that evaluate the effectiveness of different treatment modalities with a significant number of cases. We reviewed 146 cases of patients (ages ranging from 2 months old to mid 80 s) obtained from searches on PubMed, Google Scholar, and several case report journals. ECG abnormalities, elevated inflammatory markers, and reduced left ventricular ejection fraction were most associated with COVID-19 myocarditis. While classic symptoms of COVID-19 include upper respiratory symptoms, a subset of patients diagnosed with COVID-19 displayed no signs of respiratory disease at all. In 22% of cases, cardiac sequelae was not present until after the patient recovered from COVID-19. Steroids were given in 57.5% of cases. Cardiac MRI was used in 40.4% of cases for diagnosis of myocarditis. Of all the patients who were treated with ECMO, 82.1% of these patients were able to fully recover. The use of cardiac MRI and transthoracic echocardiogram for diagnosis of COVID-19 myocarditis should be heavily considered in any patient with COVID-19 infection. ECMO, IVIG, steroids, and anticoagulants should also be heavily considered. A randomized controlled trial should be conducted to better associate treatments with outcomes.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>West Virginia School of Osteopathic Medicine, 400 Lee Street North, Lewisburg, WV, 24901, USA. vlim@osteo.wvsom.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Topiwala</LastName><ForeName>Gopal</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Drexel University College of Medicine at Tower Health, 50 Innovation Way, Wyomissing, PA, 19610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apinova</LastName><ForeName>Emiliya</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>West Virginia School of Osteopathic Medicine, 400 Lee Street North, Lewisburg, WV, 24901, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diioia</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>West Virginia School of Osteopathic Medicine, 400 Lee Street North, Lewisburg, WV, 24901, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical presentations of COVID-19 associated myocarditis</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword><Keyword MajorTopicYN="N">Treatments for myocarditis</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39385302</ArticleId><ArticleId IdType="pmc">PMC11465911</ArticleId><ArticleId IdType="doi">10.1186/s12985-024-02499-4</ArticleId><ArticleId IdType="pii">10.1186/s12985-024-02499-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>“Association between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020–January 2021.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 2 Sept. 2021, www.cdc.gov/mmwr/volumes/70/wr/mm7035e5.htm.</Citation></Reference><Reference><Citation>Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, Salerno C, Hernandez-Montfort J, Islam AM. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc Revasc Med. 2021;23:107–13. 10.1016/j.carrev.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434380</ArticleId><ArticleId IdType="pubmed">32847728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismayl M, Abusnina W, Thandra A, et al. Delayed acute myocarditis with COVID-19 infection. Proc (Bayl Univ Med Cent). 2022;35(3):366–8. 10.1080/08998280.2022.2030189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9037490</ArticleId><ArticleId IdType="pubmed">35518805</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–71. 10.1016/j.hrthm.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns L, Abed El Khaleq Y, Storrar W, Scheuermann-Freestone M. COVID-19 myopericarditis with cardiac tamponade in the absence of respiratory symptoms: a case report. J Med Case Rep. 2021;15(1):31. 10.1186/s13256-020-02618-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833446</ArticleId><ArticleId IdType="pubmed">33494822</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayegh MN, Goins AE, Hall MAK, Shin YM. Presentations, diagnosis, and treatment of post-COVID viral myocarditis in the inpatient setting: a narrative review. Cureus. 2023;15(5): e39338. 10.7759/cureus.39338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10292156</ArticleId><ArticleId IdType="pubmed">37378093</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583–90. 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluckman T, Bhave N, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play. J Am Coll Cardiol. 2022;79(17):1717–56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatipoglu S, Lyon AR, Pennell DJ. CMR unveiling the cause of post CoVid-19 infection chest pain. Int J Cardiovasc Imaging. 2021;37(6):2025–6. 10.1007/s10554-021-02161-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841042</ArticleId><ArticleId IdType="pubmed">33507427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao F, Shi G, Wu Z, Guo Z. A successful rescue of juvenile fulminant myocarditis by extracorporeal membrane oxygenation combined with intra-aortic balloon pump: a case report. Ann Transl Med. 2021;9(16):1355. 10.21037/atm-21-3959</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8422090</ArticleId><ArticleId IdType="pubmed">34532492</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitrago DH, Munoz J, Finkelstein ER, Mulinari L. A case of fulminant myocarditis due to COVID-19 in an adolescent patient successfully treated with venous arterial ECMO as a bridge to recovery. J Card Surg. 2022;37(5):1439–43. 10.1111/jocs.16313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115159</ArticleId><ArticleId IdType="pubmed">35152456</ArticleId></ArticleIdList></Reference><Reference><Citation>Haussner W et al. COVID-19 associated myocarditis: a systematic review. Am J Emergency Med, 2021, 51: 150–155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8531234</ArticleId><ArticleId IdType="pubmed">34739868</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu VH, Nguyen MTT, Nguyen KD, Pham TTH, Truong BQ. A case of COVID-19-induced delayed-onset myocarditis. Am J Case Rep. 2022;23:e935577. 10.12659/AJCR.935577</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9108681</ArticleId><ArticleId IdType="pubmed">35535009</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrami B, Davoudi-Monfared E, Rezaie Z, et al. Management of a critically ill patient with COVID-19-related fulminant myocarditis: a case report. Respir Med Case Rep. 2022;36(101611): 101611. 10.1016/j.rmcr.2022.101611davi.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8857078</ArticleId><ArticleId IdType="pubmed">35223423</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadremomtaz A, Hashemi J, Sahebnasagh A, et al. A possible guide as a tool to complementary effects of new Coronavirus. Arch Anesthesia Critic Care. 2021. 10.18502/aacc.v7i4.7633</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>